[Systemic treatment of renal-cell carcinoma--present status].
Steiner
T
T
Klinik und Poliklinik für Urologie, der Friedrich-Schiller-Universität Jena, Germany. thomas.steiner@med.uni-jena.de
Schubert
J
J
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000276:immunology / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D006801:Humans; D007167:Immunotherapy; D007372:Interferons / Q000627:therapeutic use; D007378:Interleukins / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000276:immunology / Q000628:therapy*; D016019:Survival Analysis; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D007378:Interleukins; D007372:Interferons
Systemische Behandlung des Nierenzellkarzinoms--eine Standortbestimmung.